Guggenheim Reiterates Neutral Rating for Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Wednesday,Benzinga reports. A number of other equities analysts also recently commented on the company. Bank of America lifted their target price on Johnson & Johnson from $159.00 […]
Johnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “neutral” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Wednesday,Benzinga reports. A number of other equities analysts also recently commented on the company. Bank of America lifted their target price on Johnson & Johnson from $159.00 […]
